Earth Science Tech, Inc. (OTC: ETST) has reported fiscal first-quarter 2027 results, revealing a 57% year-over-year increase in net income to $715,697. The company's revenue reached $9.0 million, a 3% rise from the prior-year period, while gross profit climbed to $6.3 million. Operating cash flow more than doubled to $707,131, and total assets increased to $10.4 million. Diluted earnings per share improved to $0.003 from $0.001, and the company repurchased and retired over 3.7 million common shares during the quarter without incurring additional debt.
These results underscore the company's robust financial health and its ability to generate substantial shareholder value. The significant increase in net income and operating cash flow indicates strong operational efficiency and profitability across its business segments. Notably, all key operating subsidiaries remained profitable, reflecting the success of the company's diversified healthcare platform.
Earth Science Tech's strategic focus on expanding its compounding pharmacy operations across the United States has been a key driver of its growth. The company is also evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms, which could further enhance its market presence and revenue streams. This expansion aligns with the growing demand for integrated healthcare solutions that combine consultation, treatment, and direct-to-patient fulfillment.
The company's management is set to discuss these results and strategic initiatives at its annual shareholder meeting on Aug. 31, 2026. Investors will vote on proposals including the cancellation of the company's Series B Preferred Stock, a move that could simplify the capital structure and potentially improve investor sentiment. Additionally, updates on a potential exchange uplisting will be provided, aimed at improving liquidity and market visibility. Such a listing could attract a broader investor base and increase trading activity.
The financial performance and strategic moves by Earth Science Tech are significant for investors and the health and wellness sector. The company's ability to increase profitability while expanding its operational footprint demonstrates a scalable business model. The potential uplisting and cancellation of preferred stock are strategic steps that could unlock additional value for shareholders.
For more details on the full press release, visit https://ibn.fm/WHicW.
